Zdrowie i gospodarka · 27.06.1994
Opportunity For Licensing: Transforming Growth Factor-Beta
The National Institutes of Health (NIH) seeks a licensee to develop transforming growth factor-beta (TGF-beta) for preclinical, clinical, and commercial use, with new fields of use available for licensing, including soft tissue repair and vascular ischemia treatment.